Citing the BQC19
BQC19 Authorship policy
The contribution of the BQC19 to any scientific product must be mentioned in the acknowledgments section of any scientific communication (oral or poster presentation, journal article) using data or samples from the BQC19. The following text may be used:
This work was made possible through open sharing of data and samples from the Biobanque québécoise de la COVID-19, funded by the Fonds de recherche du Québec - Santé, Génome Québec, the Public Health Agency of Canada and, as of March 2022, the ministère de la Santé et des Services sociaux. We thank all participants to BQC19 for their contribution.
In addition, the following article describing the BQC19 should be cited in reference:
Tremblay K, Rousseau S, Zawati MH, Auld D, Chassé M, Coderre D, Falcone EL, Gauthier N, Grandvaux N, Gros-Louis F, Jabet C, Joly Y, Kaufmann DE, Laprise C, Larochelle C, Maltais F, Mes-Masson AM, Montpetit A, Piché A, Richards JB, Tse SM, Turgeon AF, Turecki G, Vinh DC, Wang HT, Mooser V; BQC19. The Biobanque québécoise de la COVID19 (BQC19)-A cohort to prospectively study the clinical and biological determinants of COVID-19 clinical trajectories. PLoS One. 2021 May 19;16(5):e0245031. doi: 10.1371/journal.pone.0245031. PMID: 34010280; PMCID: PMC8133500.
Whenever possible, the keyword BQC19 should be included in the list of keywords associated with the work.
In addition, when using certain data domains, scientific publications describing the methodology through which the data was produced should also be cited.
When using a secondary data domain (data generated by researchers using data or samples from BQC19), the original article that described this data should be cited. Researchers are invited to collaborate with the teams that generated the data to ensure the optimal use and recognition of each other's work.
